These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38051295)

  • 1. ROS-Scavenging Lignin-Based Tolerogenic Nanoparticle Vaccine for Treatment of Multiple Sclerosis.
    Phan NM; Nguyen TL; Shin H; Trinh TA; Kim J
    ACS Nano; 2023 Dec; 17(24):24696-24709. PubMed ID: 38051295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive biomaterial-based therapeutic vaccine to treat multiple sclerosis via re-establishing immune tolerance.
    Nguyen TL; Choi Y; Im J; Shin H; Phan NM; Kim MK; Choi SW; Kim J
    Nat Commun; 2022 Dec; 13(1):7449. PubMed ID: 36460677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
    Moorman CD; Bastian AG; DeOca KB; Mannie MD
    J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
    Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
    Front Immunol; 2018; 9():3119. PubMed ID: 30687323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct modulation of myelin-autoreactive CD4
    Pei W; Wan X; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    Int J Nanomedicine; 2018; 13():3731-3750. PubMed ID: 29983566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of ROS-Scavenging Cerium Oxide Nanoparticles Simply Mixed with Autoantigenic Peptides Induce Antigen-Specific Immune Tolerance against Autoimmune Encephalomyelitis.
    Nguyen TL; Phan NM; Kim J
    ACS Appl Mater Interfaces; 2024 Jul; 16(26):33106-33120. PubMed ID: 38906850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerogenic Nanovaccine for Prevention and Treatment of Autoimmune Encephalomyelitis.
    Park J; Le QV; Wu Y; Lee J; Oh YK
    Adv Mater; 2023 Jan; 35(1):e2202670. PubMed ID: 36208089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerogenic nanoparticles suppress central nervous system inflammation.
    Kenison JE; Jhaveri A; Li Z; Khadse N; Tjon E; Tezza S; Nowakowska D; Plasencia A; Stanton VP; Sherr DH; Quintana FJ
    Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32017-32028. PubMed ID: 33239445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG
    Triantafyllakou I; Clemente N; Khetavat RK; Dianzani U; Tselios T
    Mol Pharm; 2022 Nov; 19(11):3795-3805. PubMed ID: 36098508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).
    Abbott DJ; Blanchfield JL; Martinson DA; Russell SC; Taslim N; Curtis AD; Mannie MD
    BMC Immunol; 2011 Dec; 12():72. PubMed ID: 22208499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual peptide nanoparticle platform for enhanced antigen-specific immune tolerance for the treatment of experimental autoimmune encephalomyelitis.
    Wang H; Shang J; He Z; Zheng M; Jia H; Zhang Y; Yang W; Gao X; Gao F
    Biomater Sci; 2022 Jul; 10(14):3878-3891. PubMed ID: 35686489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of EAE by tolerogenic vaccination with PEGylated antigenic peptides.
    Pfeil J; Simonetti M; Lauer U; von Thülen B; Durek P; Poulsen C; Pawlowska J; Kröger M; Krähmer R; Leenders F; Hoffmann U; Hamann A
    Ther Adv Chronic Dis; 2021; 12():20406223211037830. PubMed ID: 34408824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells.
    Kim TW; Kim Y; Jung W; Kim DE; Keum H; Son Y; Jon S
    J Control Release; 2021 Mar; 331():74-84. PubMed ID: 33450316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.
    Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U
    Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
    Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
    J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
    Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
    J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of MS-like disease by a multi epitope protein is mediated by induction of CD11c
    Kaushansky N; Kaminitz A; Allouche-Arnon H; Ben-Nun A
    J Neuroimmunol; 2019 Aug; 333():476953. PubMed ID: 31108399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
    Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
    J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis.
    Au KM; Tisch R; Wang AZ
    Adv Mater; 2022 Feb; 34(5):e2107392. PubMed ID: 34775659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.